Baolingbao BiologyLtd Management
Management criteria checks 1/4
Baolingbao BiologyLtd's CEO is Qiang Wang, appointed in Jun 2023, has a tenure of 2.42 years. directly owns 0.028% of the company’s shares, worth CN¥1.16M. The average tenure of the management team and the board of directors is 5 years and 2.3 years respectively.
Key information
Qiang Wang
Chief executive officer
CN¥1.2m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 2.4yrs |
| CEO ownership | 0.03% |
| Management average tenure | 5yrs |
| Board average tenure | 2.3yrs |
Recent management updates
Recent updates
A Look At The Intrinsic Value Of Baolingbao Biology Co.,Ltd. (SZSE:002286)
Nov 29
Baolingbao BiologyLtd (SZSE:002286) Strong Profits May Be Masking Some Underlying Issues
Nov 05Baolingbao Biology Co.,Ltd.'s (SZSE:002286) Shares Climb 36% But Its Business Is Yet to Catch Up
Oct 08We Like These Underlying Return On Capital Trends At Baolingbao BiologyLtd (SZSE:002286)
Sep 30Baolingbao Biology Co.,Ltd.'s (SZSE:002286) Business Is Yet to Catch Up With Its Share Price
Jul 03Returns On Capital At Baolingbao BiologyLtd (SZSE:002286) Have Stalled
Jun 07Earnings Troubles May Signal Larger Issues for Baolingbao BiologyLtd (SZSE:002286) Shareholders
May 06CEO
Qiang Wang (63 yo)
Mr. Qiang Wang is Director of Baolingbao Biology Co. Ltd. from July 27, 2023 and is General Manager since June 20, 2023.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Director | 2.4yrs | CN¥1.20m | 0.028% CN¥ 1.2m | |
| Financial Director & CFO | less than a year | CN¥92.30k | no data | |
| Deputy General Manager | no data | CN¥520.50k | 0.0028% CN¥ 116.9k | |
| Executive Deputy GM & Non-Independent Director | 14.8yrs | CN¥903.10k | 0.0043% CN¥ 175.4k | |
| Deputy General Manager | 7.6yrs | no data | no data |
Experienced Management: 002286's management team is seasoned and experienced (5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Director | 2.3yrs | CN¥1.20m | 0.028% CN¥ 1.2m | |
| Executive Deputy GM & Non-Independent Director | 14.8yrs | CN¥903.10k | 0.0043% CN¥ 175.4k | |
| Supervisor | 4.7yrs | CN¥70.00k | no data | |
| Independent Director | 1.6yrs | CN¥47.20k | no data | |
| Vice Chairman | 5.2yrs | CN¥1.01m | 0.0038% CN¥ 155.7k | |
| Chairman | 4.7yrs | CN¥1.52m | no data | |
| Non-Independent Director | 6.8yrs | CN¥951.70k | 0.0038% CN¥ 155.7k | |
| Independent Directors | 1.6yrs | CN¥47.20k | no data | |
| Supervisor | 1.8yrs | no data | no data | |
| Independent Director | 1.6yrs | CN¥47.20k | no data | |
| Chairman of the Board of Supervisors | 1.6yrs | no data | 0.00079% CN¥ 32.5k |
Experienced Board: 002286's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/14 03:41 |
| End of Day Share Price | 2025/11/14 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Baolingbao Biology Co.,Ltd. is covered by 7 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yalei Yan | Bohai Securities Co., Ltd. |
| Xia Sheng | Citic Securities Co., Ltd. |
| Jie Li | Everbright Securities Co. Ltd. |